Clinical trial

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

NCT07220954

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-11-11

PhasePHASE1

Study timeline

Study start (actual)2025-11-11Date precision: day

Registry last updated2026-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy Participantsunresolved

Interventions

AZD6234 Formulation 1DRUG

AZD6234 Formulation 2 (low concentration)DRUG

AZD6234 Formulation 2 (high concentration)DRUG

AZD6234 Formulation 3DRUG

Sponsors & collaborators

AstraZenecalead sponsor

Quotient Sciencescollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07220954 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.